102 results
Page 2 of 6
6-K
axze0
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-99.1
29wan45wctcdm8lgyh7x
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
20-F/A
brhcacmfuh
3 Mar 22
Annual report (foreign) (amended)
6:57pm
SUPPL
hqy8me
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
n6dk66
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B5
ry2s16r72cx1c6y
8 Mar 21
Prospectus supplement for primary offering
5:03pm
424B2
0mogr1 9qh
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.1
cu0cfkq
4 Mar 21
Current report (foreign)
8:09am
6-K
EX-99.1
ijkfl5sw0xnng2
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
oa7wgv punu
24 Feb 21
Shelf registration (foreign)
5:22pm
8-A12B
cbyt2q735o0qvee50
18 Feb 21
Registration of securities on exchange
12:46pm
6-K
EX-99.1
64q y0ap2
1 Dec 20
Condensed Consolidated Interim Financial Statements
7:13am
6-K
EX-99.1
7qwr p1wifiscr
16 Oct 20
Consolidated Interim Financial Statements
2:44pm
6-K
EX-99.1
kgjskep4um h7j81r1vg
13 Oct 20
Portage Issues Common Shares and Warrants In Settlement of Salvarx Loan Note Obligations
10:15am
6-K
xh90181b
17 Jun 20
Report of Foreign Private Issuer
10:46am
6-K
s7rz1afl4i oc8p16
26 May 20
Report of Foreign Private Issuer
5:19pm
6-K
EX-99.2
th4f4rdx39p 9ur303yt
3 Mar 20
Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
odg91 8mv
3 Mar 20
Consolidated Interim Financial Statements
12:00am